Cancer-related fatigue: A practical review

Annals of Oncology

Volumn 22, Issue 6, 2011, Pages 1273-1279

  Campos, M P O ^a   Hassan, B J ^b   Riechelmann, R ^c   Del Giglio, A ^c,d  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Department of Medicine   (Brazil)

^c FACULDADE DE MEDICINA DO ABC   (Brazil)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer; Fatigue; Review

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CENTRAL STIMULANT AGENT; CORTICOSTEROID; DEXAMPHETAMINE; DEXMETHYLPHENIDATE; DONEPEZIL; ERYTHROPOIETIN; HEMOGLOBIN; METHYLPHENIDATE; METHYLPREDNISOLONE; MODAFINIL; MULTIVITAMIN; NARCOTIC AGENT; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PAROXETINE; PLACEBO; RECOMBINANT ERYTHROPOIETIN; STEROID;

ACUPRESSURE; ACUPUNCTURE; ALTERNATIVE MEDICINE; ANEMIA; BLOOD TRANSFUSION; BRIEF FATIGUE INVENTORY; CANCER FATIGUE; CANCER PATIENT; CANCER SCREENING; CLINICAL ASSESSMENT; COGNITIVE THERAPY; CONSULTATION; DRUG POTENTIATION; DRUG SAFETY; ENERGY CONSERVATION; EXERCISE; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; HYPNOSIS; LABORATORY TEST; LEISURE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL HISTORY; MULTIDIMENSIONAL FATIGUE SYMTOM INVENTORY SHORT FORM; NUTRITIONAL COUNSELING; PATIENT EDUCATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSYCHOEDUCATION; QUALITY OF LIFE; REVIEW; SLEEP THERAPY; THE FUNCTIONAL ASSESSMENT OF CANCER THERAPY INSTRUMENT; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE;

EID: 79957804151     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq458     Document Type: Review

References (100)

1. Gupta D, Lis CG, Grutsch JF. The relationship between cancer-related fatigue and patient satisfaction with quality of life in cancer. J Pain Symptom Manage 2007; 34(1): 40-47.
2. Stone P, Richardson A, Ream E. et al. Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann Oncol 2000; 11(8): 971-975.
3. Lis CG, Rodeghier M, Grutsch JF, Gupta D. Distribution and determinants of patient satisfaction in oncology with a focus on health related quality of life. BMC Health Serv Res 2009; 9: 190.
4. Mock V, Atkinson A, Barsevick A. et al. NCCN practice guidelines for cancerrelated fatigue. Oncology (Williston Park) 2000; 14(11A): 151-161.
5. Curt GA, Breitbart W, Cella D. et al. Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 2000; 5(5): 353-360.
6. Vogelzang NJ, Breitbart W, Cella D. et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 1997; 34 (3 Suppl 2): 4-12.
7. Stasi R, Abriani L, Beccaglia P. et al. Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer 2003; 98(9): 1786-1801.
8. Flechtner H, Bottomley A. Fatigue and quality of life: lessons from the real world. Oncologist 2003; 8 (Suppl 1): 5-9.
9. Wang XS, Giralt SA, Mendoza TR. et al. Clinical factors associated with cancerrelated fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma. J Clin Oncol 2002; 20(5): 1319-1328.
10. Cella D, Davis K, Breitbart W. et al. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 2001; 19(14): 3385-3391.
11. Gutstein HB. The biologic basis of fatigue. Cancer 2001; 92 (6 Suppl): 1678-1683.
12. Parker KP, Bliwise DL, Ribeiro M. et al. Sleep/wake patterns of individuals with advanced cancer measured by ambulatory polysomnography. J Clin Oncol 2008; 26(15): 2464-2472.
13. Cleeland CS, Bennett GJ, Dantzer R. et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokineimmunologic model of cancer symptoms. Cancer 2003; 97(11): 2919-2925.
14. Collado-Hidalgo A, Bower JE, Ganz PA. et al. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 2006; 12(9): 2759-2766.
15. Scott HR, McMillan DC, Brown DJ. et al. The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable nonsmall cell lung cancer. Br J Cancer 2002; 87(3): 264-267.
16. Fan HG, Houé dé -Tchen N, Yi QL. et al. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1-and 2-year follow-up of a prospective controlled study. J Clin Oncol 2005; 23(31): 8025-8032.
17. Lundstrom S, Furst CJ. Symptoms in advanced cancer: relationship to endogenous cortisol levels. Palliat Med 2003; 17(6): 503-508.
18. Scott HR, McMillan DC, Brown DJ. et al. A prospective study of the impact of weight loss and the systemic inflammatory response on quality of life in patients with inoperable non-small cell lung cancer. Lung Cancer 2003; 40(3): 295-299.
19. Bower JE, Ganz PA, Aziz N, Fahey JL. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 2002; 64(4): 604-611.
20. Bower JE, Ganz PA, Aziz N. et al. T-cell homeostasis in breast cancer survivors with persistent fatigue. J Natl Cancer Inst 2003; 95(15): 1165-1168.
21. Levy MR. Cancer fatigue: a neurobiological review for psychiatrists. Psychosomatics 2008; 49(4): 283-291.
22. Ryan JL, Carroll JK, Ryan EP. et al. Mechanisms of cancer-related fatigue. Oncologist 2007; 12 (Suppl 1): 22-34.
23. Jereczek-Fossa BA, Marsiglia HR, Orecchia R. Radiotherapy-related fatigue. Crit Rev Oncol Hematol 2002; 41(3): 317-325.
24. Malik UR, Makower DF, Wadler S. Interferon-mediated fatigue. Cancer 2001; 92 (6 Suppl): 1664-1668.
25. Atkins MB, Mier JW, Parkinson DR. et al. Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. N Engl J Med 1988; 318(24): 1557-1563.
26. Jereczek-Fossa BA, Santoro L, Alterio D. et al. Fatigue during head-and-neck radiotherapy: prospective study on 117 consecutive patients. Int J Radiat Oncol Biol Phys 2007; 68(2): 403-415.
27. Littlewood TJ, Kallich JD, San Miguel J. et al. Efficacy of darbepoetin alfa in alleviating fatigue and the effect of fatigue on quality of life in anemic patients with lymphoproliferative malignancies. J Pain Symptom Manage 2006; 31(4): 317-325.
28. Patrick DL, Ferketich SL, Frame PS. et al. National Institutes of Health State-ofthe-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15-17, 2002. J Natl Cancer Inst 2003; 95(15): 1110-1117.
29. Luthy C, Cedraschi C, Pugliesi A. et al. Patients' views about causes and preferences for the management of cancer-related fatigue-a case for noncongruence with the physicians? Support Care Cancer 2010 Feb 19. [Epub ahead of print].
30. Mendoza TR, Wang XS, Cleeland CS. et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 1999; 85(5): 1186-1196.
31. Alexander S, Minton O, Stone PC. Evaluation of screening instruments for cancer-related fatigue syndrome in breast cancer survivors. J Clin Oncol 2009; 27(8): 1197-1201.
32. Stein KD, Jacobsen PB, Blanchard CM. et al. Further validation of the multidimensional fatigue symptom inventory-short form. J Pain Symptom Manage 2004; 27(1): 14-23.
33. Knobel H, Håvard Loge J, Brit Lund M. et al. Late medical complications and fatigue in Hodgkin's disease survivors. J Clin Oncol 2001; 19(13): 3226-3233.
34. Escalante CP, Kallen MA, Valdres RU. et al. Outcomes of a cancer-related fatigue clinic in a comprehensive cancer center. J Pain Symptom Manage 2010; 39(4): 691-701.
35. Lotfi-Jam K, Carey M, Jefford M. et al. Nonpharmacologic strategies for managing common chemotherapy adverse effects: a systematic review. J Clin Oncol 2008; 26(34): 5618-5629.
36. Boesen EH, Ross L, Frederiksen K. et al. Psychoeducational intervention for patients with cutaneous malignant melanoma: a replication study. J Clin Oncol 2005; 23(6): 1270-1277.
37. Weis J. Support groups for cancer patients. Support Care Cancer 2003; 11(12): 763-768.
38. Trijsburg RW, van Knippenberg FC, Rijpma SE. Effects of psychological treatment on cancer patients: a critical review. Psychosom Med 1992; 54(4): 489-517.
39. Luebbert K, Dahme B, Hasenbring M. The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: a meta-analytical review. Psychooncology 2001; 10(6): 490-502.
40. Jacobsen PB, Meade CD, Stein KD. et al. Efficacy and costs of two forms of stress management training for cancer patients undergoing chemotherapy. J Clin Oncol 2002; 20(12): 2851-2862.
41. Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology 2004; 29(4): 448-474.
42. Decker TW, Cline-Elsen J, Gallagher M. Relaxation therapy as an adjunct in radiation oncology. J Clin Psychol 1992; 48(3): 388-393.
43. Given C, Given B, Rahbar M. et al. Effect of a cognitive behavioral intervention on reducing symptom severity during chemotherapy. J Clin Oncol 2004; 22(3): 507-516.
44. Gaston-Johansson F, Fall-Dickson JM, Nanda J. et al. The effectiveness of the comprehensive coping strategy program on clinical outcomes in breast cancer autologous bone marrow transplantation. Cancer Nurs 2000; 23(4): 277-285.
45. Gielissen MF, Verhagen S, Witjes F, Bleijenberg G. Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: a randomized controlled trial. J Clin Oncol 2006; 24(30): 4882-4887.
46. Stanton AL, Ganz PA, Kwan L. et al. Outcomes from the Moving Beyond Cancer psychoeducational, randomized, controlled trial with breast cancer patients. J Clin Oncol 2005; 23(25): 6009-6018.
47. Yates P, Aranda S, Hargraves M. et al. Randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol 2005; 23(25): 6027-6036.
48. Ream E, Richardson A, Alexander-Dann C. Supportive intervention for fatigue in patients undergoing chemotherapy: a randomized controlled trial. J Pain Symptom Manage 2006; 31(2): 148-161.
49. Goedendorp MM, Gielissen MF, Verhagen CA, Bleijenberg G. Psychosocial interventions for reducing fatigue during cancer treatment in adults. Cochrane Database Syst Rev 2009; (1): CD006953.
50. Barsevick AM, Dudley W, Beck S. et al. A randomized clinical trial of energy conservation for patients with cancer-related fatigue. Cancer 2004; 100(6): 1302-1310.
51. Hilarius DL, Kloeg PH, van der Wall E. et al. Cancer-related fatigue: clinical practice versus practice guidelines. Support Care Cancer 2010 Mar 19. [Epub ahead of print].
52. VelthuisMJ, Agasi-Idenburg SC, Aufdemkampe G,Wittink HM. The effect of physical exercise on cancer-related fatigue during cancer treatment: a meta-analysis of randomised controlled trials. Clin Oncol (R Coll Radiol) 2010; 22(3): 208-221.
53. Segal R, Evans W, Johnson D. et al. Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial. J Clin Oncol 2001; 19(3): 657-665.
54. Thorsen L, Skovlund E, Strømme SB. et al. Effectiveness of physical activity on cardiorespiratory fitness and health-related quality of life in young and middleaged cancer patients shortly after chemotherapy. J Clin Oncol 2005; 23(10): 2378-2388.
55. Dimeo F, Fetscher S, Lange W. et al. Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high-dose chemotherapy. Blood 1997; 90(9): 3390-3394.
56. Windsor PM, Nicol KF, Potter J. A randomizeed, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma. Cancer 2004; 101(3): 550-557.
57. Dimeo F, Schwartz S, Fietz T. et al. Effects of endurance training on the physical performance of patients with hematological malignancies during chemotherapy. Support Care Cancer 2003; 11(10): 623-628.
58. Griffith K, Wenzel J, Shang J. et al. Impact of a walking intervention on cardiorespiratory fitness, self-reported physical function, and pain in patients undergoing treatment for solid tumors. Cancer 2009; 115(20): 4874-4884.
59. Courneya KS, Sellar CM, Stevinson C. et al. Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. J Clin Oncol 2009; 27(27): 4605-4612.
60. Courneya KS, Mackey JR, Bell GJ. et al. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol 2003; 21(9): 1660-1668.
61. Dimeo FC, Stieglitz RD, Novelli-Fischer U. et al. Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer 1999; 85(10): 2273-2277.
62. Segal RJ, Reid RD, Courneya KS. et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 2003; 21(9): 1653-1659.
63. Segal RJ, Reid RD, Courneya KS. et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol 2009; 27(3): 344-351.
64. Milne HM, Wallman KE, Gordon S, Courneya KS. Effects of a combined aerobic and resistance exercise program in breast cancer survivors: a randomized controlled trial. Breast Cancer Res Treat 2008; 108(2): 279-288.
65. Adamsen L, Quist M, Andersen C. et al. Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial. BMJ 2009; 339: b3410.
66. Vallance JK. et al. Randomized controlled trial of the effects of print materials and step pedometers on physical activity and quality of life in breast cancer survivors. J Clin Oncol 2007; 25(17): 2352-2359.
67. Lucia A, Earnest C, Perez M. Cancer-related fatigue: can exercise physiology assist oncologists? Lancet Oncol 2003; 4(10): 616-625.
68. Schwartz AL. et al. Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy. Med Sci Sports Exerc 2001; 33(5): 718-723.
69. Duijts SF, Faber MM, Oldenburg HS. et al. Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and healthrelated quality of life in breast cancer patients and survivors-a meta-analysis. Psychooncology 2010 Mar 24. [Epub ahead of print].
70. Simeit R, Deck R, Conta-Marx B. Sleep management training for cancer patients with insomnia. Support Care Cancer 2004; 12(3): 176-183.
71. Berger AM, VonEssen S, Khun BR. et al. Feasibilty of a sleep intervention during adjuvant breast cancer chemotherapy. Oncol Nurs Forum 2002; 29(10): 1431-1441.
72. Berger AM, Kuhn BR, Farr LA. et al. One-year outcomes of a behavioral therapy intervention trial on sleep quality and cancer-related fatigue. J Clin Oncol 2009; 27(35): 6033-6040.
73. Vickers AJ, Straus DJ, Fearon B, Cassileth BR. Acupuncture for postchemotherapy fatigue: a phase II study. J Clin Oncol 2004; 22(9): 1731-1735.
74. Molassiotis A, Sylt P, Diggins H. The management of cancer-related fatigue after chemotherapy with acupuncture and acupressure: a randomised controlled trial. Complement Ther Med 2007; 15(4): 228-237.
75. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Cancer-and Treatment-Related Anemia. 2010 [cited 24 April 2010; Version 2. 2010]. Published by the National Comprehensive Cancer Network online at www.nccn.org.
76. Bruera E, Driver L, Barnes EA. et al. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol 2003; 21(23): 4439-4443.
77. Sarhill N, Walsh D, Nelson KA. et al. Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study. Am J Hosp Palliat Care 2001; 18(3): 187-192.
78. Schwartz AL, Thompson JA, Masood N. Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate. Oncol Nurs Forum 2002; 29(7): E85-E90.
79. Sugawara Y, Akechi T, Shima Y. et al. Efficacy of methylphenidate for fatigue in advanced cancer patients: a preliminary study. Palliat Med 2002; 16(3): 261-263.
80. Meyers CA, Weitzner MA, Valentine AD, Levin VA. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol 1998; 16(7): 2522-2527.
81. Bruera E, Chadwick S, Brenneis C. et al. Methylphenidate associated with narcotics for the treatment of cancer pain. Cancer Treat Rep 1987; 71(1): 67-70.
82. Bruera E, Valero V, Driver L. et al. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 2006; 24(13): 2073-2078.
83. Lower EE, Fleishman S, Cooper A. et al. Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial. J Pain Symptom Manage 2009; 38(5): 650-662.
84. Minton O, Richardson A, Sharpe M. et al. A systematic review and metaanalysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst 2008; 100(16): 1155-1166.
85. Jean-Pierre P, Morrow GR, Roscoe JA. et al. A phase 3 randomized, placebocontrolled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study. Cancer 2010; 116(14): 3513-3520.
86. Spathis A, Dhillan R, Booden D. et al. Modafinil for the treatment of fatigue in lung cancer: a pilot study. Palliat Med 2009; 23(4): 325-331.
87. Blackhall L, Petroni G, Shu J. et al. A pilot study evaluating the safety and efficacy of modafinal for cancer-related fatigue. J Palliat Med 2009; 12(5): 433-439.
88. Rizzo JD, Somerfield MR, Hagerty KL. et al. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. J Clin Oncol 2008; 26(1): 132-149.
89. Seidenfeld J, Piper M, Flamm C. et al. Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials. J Natl Cancer Inst 2001; 93(16): 1204-1214.
90. Ross SD, Allen IE, Henry DH. et al. Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review of the literature. Clin Ther 2006; 28(6): 801-831.
91. Engert A, Josting A, Haverkamp H. et al. Epoetin alfa in patients with advancedstage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial. J Clin Oncol 2010; 28(13): 2239-2245.
92. Bohlius J, Schmidlin K, Brillant C. et al. Erythropoietin or darbepoetin for patients with cancer. Cochrane Database Syst Rev 2006; (3): CD003407.
93. Bruera E. et al. Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat Rep 1985; 69(7-8): 751-754.
94. Bruera E, Roca E, Cedaro L. et al. Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 2007; 25(23): 3475-3481.
95. Auret KA, Schug SA, Bremner AP, Bulsara M. A randomized, double-blind, placebo-controlled trial assessing the impact of dexamphetamine on fatigue in patients with advanced cancer. J Pain Symptom Manage 2009; 37(4): 613-621.
96. de Souza Fêde AB, Bensi CG, Trufelli DC. et al. Multivitamins do not improve radiation therapy-related fatigue: results of a double-blind randomized crossover trial. Am J Clin Oncol 2007; 30(4): 432-436.
97. Morrow GR, Hickok JT, Roscoe JA. et al. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol 2003; 21(24): 4635-4641.
98. Stockler MR, O'Connell R, Nowak AK. et al. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. Lancet Oncol 2007; 8(7): 603-612.
99. Minton O, Richardson A, Sharpe M. et al. Drug therapy for the management of cancer-related fatigue. Cochrane Database Syst Rev 2010; (7): CD006704.
100. Escalante CP, Grover T, Johnson BA. et al. A fatigue clinic in a comprehensive cancer center: design and experiences. Cancer 2001; 92 (6 Suppl): 1708-1713.